Saturday, October 20, 2018

Biotech IPOs For The Week Ahead

Alzheon is a U.S. clinical-stage biopharmaceutical company developing medicines for patients suffering from Alzheimer's disease and other neurological and psychiatric disorders.

from RTT - Biotech https://ift.tt/2pZMRug
via IFTTT

No comments:

Post a Comment